Operating Lease, Liability in USD of Skye Bioscience, Inc. from Q3 2021 to Q4 2024

Taxonomy & unit: us-gaap: USD
Description: Present value of lessee's discounted obligation for lease payments from operating lease.
Summary: Skye Bioscience, Inc. quarterly Operating Lease, Liability history and change rate from Q3 2021 to Q4 2024.
Skye Bioscience, Inc. Operating Lease, Liability for the quarter ending 31 Dec 2024 was $456K, a 87.3% increase year-over-year.

Operating Lease, Liability, Quarterly (USD)

Operating Lease, Liability, YoY Quarterly Change (%)

Skye Bioscience, Inc. Quarterly Operating Lease, Liability (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q4 2024	$456K	+$212K	+87.3%	31 Dec 2024	10-K	20 Mar 2025
Q4 2023	$243K	+$165K	+209%	31 Dec 2023	10-K	20 Mar 2025
Q3 2023	$259K	+$159K	+158%	30 Sep 2023	10-Q	14 Nov 2023
Q2 2023	$274K	+$153K	+126%	30 Jun 2023	10-Q	07 Aug 2023
Q1 2023	$81.3K	-$60.2K	-42.5%	31 Mar 2023	10-Q	12 May 2023
Q4 2022	$78.7K	-$82.4K	-51.1%	31 Dec 2022	10-K	22 Mar 2024
Q3 2022	$101K	-$63.6K	-38.7%	30 Sep 2022	10-Q	14 Nov 2022
Q2 2022	$121K			30 Jun 2022	10-Q	15 Aug 2022
Q1 2022	$142K			31 Mar 2022	10-Q	06 May 2022
Q4 2021	$161K			31 Dec 2021	10-K	31 Mar 2023
Q3 2021	$164K			30 Sep 2021	10-Q	10 Nov 2021

* An asterisk sign (*) next to the value indicates that the value is likely invalid.